作者
Andreas H Jacobs, Anne Thomas, Lutz W Kracht, Huongfeng Li, Claus Dittmar, Guido Garlip, Norbert Galldiks, Johannes C Klein, Jan Sobesky, Rüdiger Hilker, Stefan Vollmar, Karl Herholz, Klaus Wienhard, Wolf-Dieter Heiss
发表日期
2005/12/1
期刊
Journal of Nuclear Medicine
卷号
46
期号
12
页码范围
1948-1958
出版商
Society of Nuclear Medicine
简介
Because of the high glucose metabolism in normal brain tissue 18F-FDG is not the ideal tracer for the detection of gliomas. Methyl-11C-l-methionine (11C-MET) is better suited for imaging the extent of gliomas, because it is transported specifically into tumors but only insignificantly into normal brain. 3′-Deoxy-3′-18F-fluorothymidine (18F-FLT) has been introduced as a proliferation marker in a variety of neoplasias and has promising potential for the detection of brain tumors, because its uptake in normal brain is low. Additionally, the longer half-life might permit differentiation between transport and intracellular phosphorylation.
Methods
PET of 18F-FLT and 11C-MET was performed on 23 patients (age range, 20–70 y) with histologically verified gliomas of different grades. On all patients, conventional MRI was performed, and 16 patients additionally underwent contrast-enhanced imaging. Images were coregistered …引用总数
学术搜索中的文章
AH Jacobs, A Thomas, LW Kracht, H Li, C Dittmar… - Journal of Nuclear Medicine, 2005